ACTINIUM PHARMACEUTICALS, INC. Public Float
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Public Float of $43.66 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $43.66M.
- 2024-06-30: Entity Public Float $226.02M.
- 2023-06-30: Entity Public Float $200.26M.
- 2022-06-30: Entity Public Float $119.59M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $43.66M 10-K · filed 2026-03-30 |
| 2024-06-30 | $226.02M 10-K · filed 2025-03-31 |
| 2023-06-30 | $200.26M 10-K · filed 2024-03-29 |
| 2022-06-30 | $119.59M 10-K · filed 2023-03-31 |
| 2021-06-30 | $138.62M 10-K · filed 2022-03-25 |
| 2020-06-30 | $138.90M 10-K · filed 2021-03-31 |
| 2019-06-28 | $39.79M 10-K · filed 2020-05-08 |
| 2018-06-29 | $70.69M 10-K · filed 2019-03-15 |
| 2017-06-30 | $71.39M 10-K · filed 2018-03-16 |
| 2016-06-30 | $80.52M 10-K · filed 2017-03-16 |
| 2015-06-30 | $102.51M 10-K · filed 2016-03-11 |
| 2014-06-30 | $199.29M 10-K · filed 2015-03-16 |
| 2013-06-28 | $56.56M 10-K · filed 2014-02-28 |
| 2012-06-30 | $0.00 10-K · filed 2013-03-29 |
| 2012-03-07 | $0.00 10-K · filed 2012-04-12 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 |
| 2010-06-30 | $0.00 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |